Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
6(85.7%)
Phase 1
1(14.3%)
7Total
N/A(6)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT02841930Not ApplicableCompleted

ActionHealthNYC Research Study

Role: collaborator

NCT02067039Not ApplicableCompleted

Evaluation of Rapid HIV Self-testing Among MSM (eSTAMP)

Role: collaborator

NCT02023580Not ApplicableCompleted

Scale-up of an Internet-Delivered Study for HIV+ Men

Role: lead

NCT00649701Phase 1Unknown

Novel Internet-Based Interventions to Reduce Sexual Risk Among Men Who Have Sex With Men

Role: lead

NCT00552539Not ApplicableCompleted

Syphilis Video Tool to Promote Knowledge and Testing in the ED

Role: collaborator

NCT00249327Not ApplicableCompleted

Online HIV Prevention Vignette Evaluation

Role: lead

NCT00273403Not ApplicableUnknown

Outcome Evaluation of Minority AIDS Initiative Programs in the New York EMA

Role: collaborator

All 7 trials loaded